Pharma: Other News To Note
Friday, August 10, 2012
Vanda Pharmaceuticals Inc., of Washington, said the Israeli Ministry of Health granted market approval for Fanapt (iloperidone) for the treatment of schizophrenia. Vanda will commercialize the drug in Israel through its partner Megapharm Ltd., of Raanana, Israel.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.